Eliminating racial disparities in colorectal cancer in the real world: it took a village.

Colorectal cancer (CRC) is the third most common cancer in the United States, with more than 102,000 new patients diagnosed per year.1 It is, however, one of the few cancers that is highly preventable through the use of routine screening,2 which can also prevent death resulting from CRC.3,4 CRC is also one cancer that continues to demonstrate widening incidence and survival disparities between whites and African Americans.1,5 Although the reasons for these disparities are multifactorial, advanced stage at diagnosis may explain up to 50% of the survival disparity.6

[1]  Adeyinka O Laiyemo,et al.  Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. , 2010, Journal of the National Cancer Institute.

[2]  C. Redmond,et al.  Determinants of black/white differences in colon cancer survival. , 1995, Journal of the National Cancer Institute.

[3]  Adrienne Y. Stith,et al.  Unequal treatment: confronting racial and ethnic disparities in health care. , 2003 .

[4]  D. Nerenz,et al.  Comorbidity and survival disparities among black and white patients with breast cancer. , 2005, JAMA.

[5]  Nancy Breen,et al.  Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United States , 2006, Cancer Epidemiology Biomarkers & Prevention.

[6]  Xianglin L. Du,et al.  Post-treatment surveillance in a large cohort of patients with colon cancer. , 2011, The American journal of managed care.

[7]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[8]  G. Swanson,et al.  Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial. , 2006, The Gerontologist.

[9]  L. Jandorf,et al.  A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. , 2008, Journal of the National Medical Association.

[10]  S. Hendren,et al.  Racial disparity in death from colorectal cancer , 2011, Cancer.

[11]  Martin Krapcho,et al.  SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .

[12]  E. Ellerbeck,et al.  Disparities in colorectal cancer screening: a guideline-based analysis of adherence. , 2006, Ethnicity & disease.

[13]  G. Fitzmaurice,et al.  Association of local capacity for endoscopy with individual use of colorectal cancer screening and stage at diagnosis , 2010, Cancer.

[14]  Jeffrey M. Ashburner,et al.  A Culturally Tailored Navigator Program for Colorectal Cancer Screening in a Community Health Center: A Randomized, Controlled Trial , 2009, Journal of General Internal Medicine.

[15]  E. Paskett Cancer health [corrected] disparities: moving from why they occur to how they can be prevented. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Eric J Feuer,et al.  Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.

[17]  B. Smedley,et al.  Unequal Treatment: Con-fronting Racial and Ethnic Disparities in Health Care , 2002 .

[18]  W. Barlow,et al.  Explaining black-white differences in receipt of recommended colon cancer treatment. , 2005, Journal of the National Cancer Institute.

[19]  L. McMahon,et al.  Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. , 1999, Medical care.

[20]  J. López,et al.  Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic , 2005, Journal of Urban Health.

[21]  A. Jemal,et al.  Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  D. Fairclough,et al.  Patient Navigation Improves Cancer Diagnostic Resolution: An Individually Randomized Clinical Trial in an Underserved Population , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[23]  E. Seiber,et al.  The Ohio Patient Navigation Research Program: Does the American Cancer Society Patient Navigation Model Improve Time to Resolution in Patients with Abnormal Screening Tests? , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[24]  Terry Hyslop,et al.  Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. , 2004, Preventive medicine.

[25]  Xianglin L. Du,et al.  Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002 , 2008, Cancer.

[26]  L. Seeff,et al.  Colorectal Cancer Test Use from the 2005 National Health Interview Survey , 2008, Cancer Epidemiology Biomarkers & Prevention.

[27]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[28]  R. Roetzheim,et al.  A Cluster Randomized Trial Evaluating the Efficacy of Patient Navigation in Improving Quality of Diagnostic Care for Patients with Breast or Colorectal Cancer Abnormalities , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[29]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.